Drug Profile
Meloxicam vaginal ring - Andromaco
Latest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Andromaco
- Class 2 ring heterocyclic compounds; Amides; Analgesics; Anti-inflammatories; Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Small molecules; Thiazines; Thiazoles
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pregnancy
Most Recent Events
- 23 Feb 2016 No recent reports on development identified - Phase-I/II for Pregnancy (Prevention) in Chile (Vaginal)
- 22 Apr 2013 Andromaco completes enrolment in its phase I/II trial for Contraception in Chile (NCT01839643)
- 01 Feb 2013 Phase-I/II clinical trials in Pregnancy (Prevention) in Chile (Vaginal)